Dyax Corp Asset Turnover Ratio (DYAX), as of third quarter 2015, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dyax Corp  (DYAX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Dyax Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Dyax's asset turnover ratio, the ratio that measures the ability of Dyax's assets to generate revenue, sequentially decreased to 0.32 in the third quarter (Sep 30 2015), which does not come as a surprise, as the Dyax continue to experience difficult business climate.

Within sector 8 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2015, to 1761, from total ranking in the second quarter 2015 at 2786.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DYAX Asset Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter
Y / Y Asset Change 64.71 % 104.93 % 1.29 % 61.79 % 199.89 %
Y / Y Revenue Change 12.44 % 34.66 % 44.63 % 54.39 % 60.64 %
Asset Turnover Ratio (TTM) 0.32 0.36 0.41 0.39 0.38
DYAX's Total Ranking # 1761 # 2786 # 1730 # 2786 # 2786
Seq. Asset Change -18.39 % 102.29 % -2.67 % 2.5 % 1.54 %
Seq. Revenue Change -6.23 % 29.17 % -21.55 % 18.35 % 12.3 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 9
Healthcare Sector # 132
Overall Market # 1761

Asset Turnover Ratio Statistics
High Average Low
12.48 9.78 8.24
(Sep 30 2014)   (Sep 30 2013)




DYAX Company Profile • Back to DYAX Efficiency Comparisons • Compare DYAX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Assets at quarter ending Sep 30 2015
Zeo Scientifix Inc   0.76 $ 0.060  Millions$ 0.079  Millions
Resmed Inc   0.76 $ 1,710.160  Millions$ 2,260.883  Millions
Retractable Technologies Inc  0.75 $ 33.094  Millions$ 43.880  Millions
Tearlab Corp  0.75 $ 23.661  Millions$ 31.441  Millions
Neogen Corporation  0.75 $ 290.335  Millions$ 386.480  Millions
Quest Diagnostics Inc  0.75 $ 7,527.000  Millions$ 10,071.000  Millions
Positron Corporation  0.74 $ 1.237  Millions$ 1.679  Millions
Rti Surgical Holdings Inc   0.73 $ 277.045  Millions$ 377.746  Millions
United Therapeutics Corporation  0.73 $ 1,407.250  Millions$ 1,918.770  Millions
Zoetis Inc   0.73 $ 4,811.000  Millions$ 6,580.250  Millions
Cyteir Therapeutics Inc   0.72 $ 2,005.300  Millions$ 2,768.600  Millions
Intelgenx Technologies Corp   0.72 $ 4.418  Millions$ 6.162  Millions
Incyte Corporation  0.71 $ 633.843  Millions$ 888.741  Millions
Merit Medical Systems Inc  0.71 $ 536.525  Millions$ 752.588  Millions
Charles River Laboratories International inc   0.70 $ 1,339.000  Millions$ 1,912.795  Millions
Pra Health Sciences Inc   0.70 $ 1,554.900  Millions$ 2,228.199  Millions
Halozyme Therapeutics Inc   0.69 $ 113.207  Millions$ 164.471  Millions
Pacific Biosciences Of California Inc   0.69 $ 73.405  Millions$ 106.873  Millions
Enanta Pharmaceuticals Inc  0.68 $ 160.880  Millions$ 236.275  Millions
Alphatec Holdings Inc   0.68 $ 191.903  Millions$ 281.896  Millions
Bard C R Inc  0.68 $ 3,412.400  Millions$ 5,022.300  Millions
Integer Holdings Corporation  0.68 $ 652.573  Millions$ 963.121  Millions
Icad Inc  0.67 $ 47.110  Millions$ 69.837  Millions
Edwards Lifesciences Corporation  0.67 $ 2,440.600  Millions$ 3,624.400  Millions
Veracyte Inc   0.67 $ 47.660  Millions$ 70.814  Millions
Pediatrix Medical Group Inc   0.67 $ 2,688.781  Millions$ 4,019.186  Millions
Navidea Biopharmaceuticals Inc   0.67 $ 10.416  Millions$ 15.630  Millions
Surmodics Inc   0.66 $ 61.898  Millions$ 93.129  Millions
Conmed Corporation  0.66 $ 723.154  Millions$ 1,092.343  Millions
United Cannabis Corp  0.65 $ 0.631  Millions$ 0.974  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.